Guidelines for the examination of pharmaceutical patents (original) (raw)
Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective, ICTSD, WHO, UNCTAD, Geneva
carlos correa
View PDFchevron_right
The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPS Provisions†
Jerome Reichman
Journal of International Economic Law - J INT ECON LAW, 2007
View PDFchevron_right
Doha Declaration and access to drugs and medicines
Anjali Mohandas
View PDFchevron_right
TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?
Vanessa Kerry
Globalization and Health, 2007
View PDFchevron_right
Public health and international patent protection
Pranjal Khare
International journal of health sciences
View PDFchevron_right
TRIPS-Plus Free Trade Agreements and Access to Medicines
Susan Sell
Liverpool Law Review, 2007
View PDFchevron_right
Patents and Public Health in the WTO, FTAs and Beyond: Tension and Conflict in International Law
Tania Voon, Andrew D Mitchell
View PDFchevron_right
Trade Rules and Intellectual Property Protection for Pharmaceuticals
Valbona Muzaka
View PDFchevron_right
The TAFTA, TTIP, and Treatment Access: What Does the Agreement Mean for Intellectual Property Rights Over Essential Medicines?
Faisal Chaudhry
The Transatlantic Colossus,: lobal Contributions To Broaden The Debate On The EU-US Free Trade Agreement, eds. David Cardoso, et al.., 2014
View PDFchevron_right
Effects of TRIPSPlus Provisions in International Trade Agreements upon Access to Medicines in Developing Countries
Sandeep Mittal
Journal of Intellectual Property Rights (JIPR) : [776] ISSN: 0975-1076 (Online); 0971-7544 (Print) JIPR Vol.22(6) [November 2017] Page(s): 295-302, 2017
View PDFchevron_right
PRODUCT PATENTS AND ACCESS TO INNOVATIVE MEDICINES IN A POST-TRIPS ERA
Jayashree WAtal
SSRN, 2019
View PDFchevron_right
Should access to medicines and TRIPS flexibilities be limited to specific diseases
Kevin Outterson
Am. JL & Med., 2008
View PDFchevron_right
Does the international patent regime constitute an illegitimate obstacle to Global Health and if so are there any preferable alternatives?
Ben Poser
View PDFchevron_right
Policy & practice Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016
Brigit Toebes
View PDFchevron_right
Patents for Drugs and the Right to Development in International Law
Olasupo Owoeye
Law and Development Review, 2015
View PDFchevron_right
Balancing intellectual monopoly privileges and the need for essential medicines
Thomas Faunce
Globalization and Health, 2007
View PDFchevron_right
Implications of bilateral free trade agreements on access to medicines
Carlos Correa
Bulletin of The World Health Organization, 2006
View PDFchevron_right
Intellectual Property Rights In Bilateral Investment Treaties and Access to Medicines: the Case of Latin America
Rosa Castro
The Journal of World Intellectual Property, 2006
View PDFchevron_right
Excessive prices and access to medicines – Compulsory licensing as an anticompetitive remedy under the TRIPS Agreement
Behrang Kianzad
2019
View PDFchevron_right
Reconciling the global public health interest with intellectual property protection through the waiver of certain provisions of the WTO TRIPS Agreement
Patrick Osode
Yuridika, 2022
View PDFchevron_right
The T(i)PP(ing) Point for Pharma: Why having TRIPS+ patenting standards in the TPP is bad news for Developing Countries
Akhil Raina
2017
View PDFchevron_right
Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Jorge Antonio
Bulletin of the World …, 2004
View PDFchevron_right
Arthritic flexibilities for accessing medicines: analysis of WTO action regarding Paragraph 6 of the Doha Declaration on the Trips Agreement and Public Health
brook baker
Ind. Int'l & Comp. L. Rev., 2003
View PDFchevron_right
Morin, J-F., 2006, "Tripping up TRIPs Debate: IP and Health ", International Journal of Intellectual Property Management, vol. 1, no1/2, p. 37-53.
Jean-Frederic Morin
International Journal of Intellectual Property …, 2006
View PDFchevron_right
Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016
Brigit Toebes
Bulletin of the World Health Organization, 2018
View PDFchevron_right
Lisa Forman, "Human Rights Impact Assessment Of Trade-Related Intellectual Property Rights: A Key Strategy In Post-2015 Efforts To Improve Access To Safe And Accessible Medicines" (2013)
Lisa Forman
(2013) 1:1 Journal of Health Diplomacy
View PDFchevron_right
Patents, trade and medicines: past, present and future
Amy Kapczynski
Review of International Political Economy, 2019
View PDFchevron_right
Canadian-made Drugs for Rwanda: The first application of the WTO waiver on patents and medicines
Holger Hestermeyer
American Society of International Law Insights, 2007
View PDFchevron_right
The WTO’s Compulsory Licencing of Patented Pharmaceuticals: Implementation Challenges
Milorad Stamenovic
Međunarodna politika 75(1190):39-55, 2024
View PDFchevron_right
Reframing the issue: The WTO coalition on intellectual property and public health, 2001
Susan Sell
… , ed. Negotiating Trade: Developing Countries in …, 2006
View PDFchevron_right
Analysis of TRIPS Agreement and the justification of international IP rights protection in the WTO's multilateral trading system, with particular reference to pharmaceutical patents
Jae Sundaram
Information & Communications Technology Law, 2015
View PDFchevron_right
TRIPS PLUS MEASURES UNDER RCEP NEGOTIATIONS THREATEN PUBLIC ACCESS TO MEDICINES
Eva Novi Karina
View PDFchevron_right
Submission to the United Nations Secretary General's High Level Panel on Access to Medicines
Dinar Kale
2016
View PDFchevron_right
AIDS and TRIPS Pharmaceutical Patents, Generic Drugs and Public Health Under The TRIPS Agreement
fabienne orsi
View PDFchevron_right
The Inadequate Global Policy Response to Trade-Related Intellectual Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries
Lisa Forman
Maryland Journal of International Law, 2016
View PDFchevron_right